IBX

0.00%

4.0¢ imagion biosystems limited

Hi TurtlespeedAs I have argued previously, it goes to directors...

First 5081 Last

Share
Profile

Follow
bkkrunner

92 Posts.

58

06/10/21

13:35

Post #: 56603609
Share

Originally posted by turtlespeed: ↑

Seem like Covid is not much of an excuse according to the Government , in 2020 there was only a 4% reduction in Breast Cancer diagnosis. If you read the document it was March, April and early May that was affected then they started catching up.

It's expected 19866 women will be diagnosed with breast cancer and15% of these being Her2 , this means that 2980 women are eligible. The population of the three trial states accounting for 78% of eligible people , you would minus 22% for population and another 4% for covid, this leaves 2231 eligible women. On top of this you would have to account for people who do not use these 4 sites as they are not the only ones who deal with breast cancer so what percentage is this?. So with 1 patient enrolled in 24 May 2021 , 2nd site Austin added in the half year , 3rd site Royal Brisbane's Women's Hospital added end of half year and a fourth site in NSW imminent , leaving the eligible Women over the last 6 months to a small percentage. According to ANZCTRas of 7July 2021 we still only had 1 patient enrolled with a target of 30. There is minimal incentive for taking part in this trial as it won't help the women diagnosed , only women in the future. The only women I can think who have a incentive to go out of their way to take part is women with a family history.

So how did Bob not account for the small demographic and one trial site when designing the trial , I think it is because his background is Sales and Marketing not Trial design and deployment. I can only hope for a miracle firstly for the women diagnosed and second for this company and us investors.

Expand

Hi Turtlespeed

As I have argued previously, it goes to directors duties esp care, skill and diligence. What we have seen so far is a failure to meet these standards by the directors.

IBX Price at posting: 7.1¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 426 more messages in this thread...

First 5081 Last

Add IBX (ASX) to my watchlist

(20min delay)
Last 4.0¢		Change 0.000(0.00%)		Mkt cap ! $1.425M

Open	High	Low	Value	Volume
4.0¢	4.0¢	3.6¢	$27.63K	750.1K

Buyers (Bids)

No.	Vol.	Price($)
2	63865	3.7¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	25000	1

View Market Depth

No.	Vol.	Price($)
2	63865	0.037
1	28571	0.035
1	20000	0.034
2	48750	0.033
1	92000	0.032

Price($)	Vol.	No.
0.046	90637	1
0.047	14800	1
0.048	13016	2
0.050	105885	2
0.055	88714	1

Last trade - 13.05pm 04/10/2024 (20 minute delay)

IBX (ASX) Chart

Hi TurtlespeedAs I have argued previously, it goes to directors...

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi TurtlespeedAs I have argued previously, it goes to directors...

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News